28 related articles for article (PubMed ID: 13678816)
1. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
[TBL] [Abstract][Full Text] [Related]
2. PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA.
Dutta S; Snyder MJ; Rosile D; Binz KL; Roll EH; Suryadi J; Bierbach U; Guthold M
Cell Biochem Biophys; 2013; 67(3):1103-13. PubMed ID: 23636685
[TBL] [Abstract][Full Text] [Related]
3. Not the usual suspect - an unexpected organometallic product during the synthesis of cytotoxic platinum(II) complexes.
Maier T; Wutschitz J; Gajic N; Hejl M; Cseh K; Mai S; Jakupec MA; Galanski MS; Keppler BK
Dalton Trans; 2023 Nov; 52(44):16326-16335. PubMed ID: 37855721
[TBL] [Abstract][Full Text] [Related]
4. Conformational Modulation of Iduronic Acid-Containing Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound and Implications for Development of Antimetastatic Platinum Drugs.
Gorle AK; Haselhorst T; Katner SJ; Everest-Dass AV; Hampton JD; Peterson EJ; Koblinski JE; Katsuta E; Takabe K; von Itzstein M; Berners-Price SJ; Farrell NP
Angew Chem Int Ed Engl; 2021 Feb; 60(6):3283-3289. PubMed ID: 33174390
[No Abstract] [Full Text] [Related]
5. Amino Acids as Chelating Ligands for Platinum: Enhanced Stability in an Aqueous Environment Promoted by Biocompatible Molecules.
Cucchiaro A; Scherfler A; Corinti D; Berden G; Oomens J; Wurst K; Gust R; Crestoni ME; Kircher B; Cziferszky M
J Med Chem; 2023 Nov; 66(22):15256-15268. PubMed ID: 37937969
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Antiproliferative Activity, and DNA Binding Studies of Nucleoamino Acid-Containing Pt(II) Complexes.
Riccardi C; Capasso D; Coppola A; Platella C; Montesarchio D; Di Gaetano S; Roviello GN; Musumeci D
Pharmaceuticals (Basel); 2020 Sep; 13(10):. PubMed ID: 33007911
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Structural Characterization, and Evaluation of the Biological Properties of Heteroleptic Palladium(II) Complexes.
Khan H; Daraz N; Khan MN; Said M; Akhtar N; Badshah A; Khan AS; Ali M
Bioinorg Chem Appl; 2014; 2014():916361. PubMed ID: 25276113
[TBL] [Abstract][Full Text] [Related]
8. Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines.
Gabano E; Gama S; Mendes F; Gariboldi MB; Monti E; Bombard S; Bianco S; Ravera M
J Biol Inorg Chem; 2013 Oct; 18(7):791-801. PubMed ID: 23873259
[TBL] [Abstract][Full Text] [Related]
9. Identification of Binding Mode of a Platinum (II) Complex, PtCl(2)(DIP), and Calf Thymus DNA.
Shahabadi N; Kashanian S; Fatahi A
Bioinorg Chem Appl; 2011; 2011():687571. PubMed ID: 22110411
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin--DNA cross-link models with an unusual type of chirality-neutral chelate amine carrier ligand, N,N dimethylpiperazine (Me2ppz): Me2ppzPt(guanosine monophosphate)2 adducts that exhibit novel properties.
Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
Inorg Chem; 2000 Feb; 39(4):836-42. PubMed ID: 11272585
[TBL] [Abstract][Full Text] [Related]
11. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
Komeda S
Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
[TBL] [Abstract][Full Text] [Related]
12. Advancements in steroidal Pt(II) & Pt(IV) derivatives for targeted chemotherapy (2000-2023).
Sheikh HK; Ortiz CJC; Arshad T; Padrón JM; Khan H
Eur J Med Chem; 2024 May; 271():116438. PubMed ID: 38685141
[TBL] [Abstract][Full Text] [Related]
13. Platinum complexes of diaminocarboxylic acids and their ethyl ester derivatives: the effect of the chelate ring size on antitumor activity and interactions with GMP and DNA.
Moradell S; Lorenzo J; Rovira A; Robillard MS; Avilés FX; Moreno V; de Llorens R; Martinez MA; Reedijk J; Llobet A
J Inorg Biochem; 2003 Sep; 96(4):493-502. PubMed ID: 13678816
[TBL] [Abstract][Full Text] [Related]
14. Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5'-GMP and DNA.
Moradell S; Lorenzo J; Rovira A; van Zutphen S; Avilés FX; Moreno V; de Llorens R; Martinez MA; Reedijk J; Llobet A
J Inorg Biochem; 2004 Nov; 98(11):1933-46. PubMed ID: 15522419
[TBL] [Abstract][Full Text] [Related]
15. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
